Title:Exploring the Pharmacological Potential of Lobelia trigona and its
Bioactive Compounds
Volume: 5
Author(s): Ankita Moharana, Priyabati Choudhury, Snigdha Rani Behera, Pratik Kumar Vishwakarma, Shivendra Mani Tripathi*Shobhit Prakash Srivastava*
Affiliation:
- Department of Pharmaceutical
Science and Technology, Madan Mohan Malaviya University, Gorakhpur, Uttar Pradesh, India
- Dr. MC Saxena College of
Pharmacy, Lucknow, Uttar Pradesh, India
Keywords:
Lobelia trigona, yellow lobelia, lobelanidine, pharmacological effects, nanotechnology, disease.
Abstract:
Aim: The aim of this in-depth review is to provide an overview of the pharmacological
effects of Lobelia trigona and its bioactive components, highlighting its potential as a
source of medicinal agents for various diseases.
Methods: This review involved a comprehensive analysis of existing literature and research
studies on the pharmacological effects of Lobelia trigona and its bioactive compounds. A bibliography
survey was carried out using various electronic databases like Google Scholar, ScienceDirect,
Springer, Scopus, PubMed, Wiley, etc., and other offline as well as online academic
libraries were also used for the bibliography survey and compilation of data.
Results: Lobelia trigona was found to exhibit diverse pharmacological effects, primarily mediated
by bioactive alkaloids, such as lobeline, lobelanidine, and lobelanine. It demonstrated
bronchodilator effects with potential applications in respiratory conditions, analgesic and antiinflammatory
properties for treating painful and inflammatory conditions, and cardiovascular
effects, including vasodilation and hypotensive effects. The alkaloid lobeline was reported to
have promising anti-addictive effects, particularly in smoking cessation. Nanocarrier-based
formulations have the potential to address limitations, improve dosing schedules, and enhance
the pharmacological effects of Lobelia trigona.
Conclusion: Lobelia trigona demonstrates diverse pharmacological effects, primarily attributed
to its bioactive alkaloids. It holds promise as a source of medicinal agents for a range of
diseases. The potential synergy between the pharmacological effects of Lobelia trigona and
nanocarrier technology highlights the significance of nanotechnology in improving Lobelia
trigona-based therapeutics. However, further research is warranted to determine the clinical
effectiveness, safety, biocompatibility, and long-term effects of nanocarrier-based Lobelia
trigona formulations in different disease models.